Cargando…
NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling
Potentiating antitumor immunity is a promising therapeutic approach for treating a variety of cancers, including breast cancer. One potential strategy to promote antitumor immunity is targeting DNA damage response. Given that the nuclear receptor NR1D1 (also known as REV-ERBα) inhibits DNA repair in...
Autores principales: | Ka, Na-Lee, Park, Mi Kyung, Kim, Seung-Su, Jeon, Yoon, Hwang, Sewon, Kim, Sun Mi, Lim, Ga Young, Lee, Ho, Lee, Mi-Ock |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538367/ https://www.ncbi.nlm.nih.gov/pubmed/37395684 http://dx.doi.org/10.1158/0008-5472.CAN-23-0329 |
Ejemplares similares
-
DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS–STING signalling
por: Wheeler, Otto P.G., et al.
Publicado: (2023) -
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC
por: Li, Kun, et al.
Publicado: (2022) -
Induction of pro-inflammatory cytokines by 29-kDa FN-f via cGAS/STING pathway
por: Hwang, Hyun Sook, et al.
Publicado: (2019) -
Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases
por: Seok, Jin Kyung, et al.
Publicado: (2023) -
Epistatic effect of TLR3 and cGAS‐STING‐IKKε‐TBK1‐IFN signaling variants on colorectal cancer risk
por: Catalano, Calogerina, et al.
Publicado: (2019)